Mid-Infrared Photothermal Spectroscopy for the Detection of Caffeine in Beverages.
Giovanna RicchiutiLisa RiedlspergerAlicja DabrowskaErwin RosenbergLiam O'FaloainBernhard LendlPublished in: Sensors (Basel, Switzerland) (2024)
Caffeine is the most widely consumed stimulant and is the subject of significant ongoing research and discussions due to its impact on human health. The industry's need to comply with country-specific food and beverage regulations underscores the importance of monitoring caffeine levels in commercial products. In this study, we propose an alternative technique for caffeine analysis that relies on mid-infrared laser-based photothermal spectroscopy (PTS). PTS exploits the high-power output of the quantum cascade laser (QCL) sources to enhance the sensitivity of the mid-IR measurement. The laser-induced thermal gradient in the sample scales with the analytes' absorption coefficient and concentration, thus allowing for both qualitative and quantitative assessment. We evaluated the performance of our experimental PTS spectrometer, incorporating a tunable QCL and a Mach-Zehnder interferometer, for detecting caffeine in coffee, black tea, and an energy drink. We calibrated the setup with caffeine standards (0.1-2.5 mg mL -1 ) and we benchmarked the setup's capabilities against gas chromatography (GC) and Fourier-transform infrared (FTIR) spectroscopy. Quantitative results aligned with GC analysis, and limits of detection matched the research-grade FTIR spectrometer, indicating an excellent performance of our custom-made instrument. This method offers an alternative to established techniques, providing a platform for fast, sensitive, and non-destructive analysis without consumables as well as with high potential for miniaturization.
Keyphrases
- high resolution
- human health
- gas chromatography
- risk assessment
- mass spectrometry
- single molecule
- magnetic resonance imaging
- drinking water
- tandem mass spectrometry
- molecular dynamics
- cancer therapy
- magnetic resonance
- climate change
- high resolution mass spectrometry
- high speed
- drug release
- patient reported outcomes